Overview

Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
To determine the percentage of women who achieve anemia correction after a single dose of 1000mg of low molecular weight iron dextran(infed).
Phase:
Phase 2
Details
Lead Sponsor:
Auerbach Hematology Oncology Associates P C
Collaborator:
Pharmacosmos A/S
Treatments:
Dextrans
Iron
Iron-Dextran Complex